Literature DB >> 8294516

The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity.

R A Van Etten1, P K Jackson, D Baltimore, M C Sanders, P T Matsudaira, P A Janmey.   

Abstract

The myristoylated form of c-Abl protein, as well as the P210bcr/abl protein, have been shown by indirect immunofluorescence to associate with F-actin stress fibers in fibroblasts. Analysis of deletion mutants of c-Abl stably expressed in fibroblasts maps the domain responsible for this interaction to the extreme COOH-terminus of Abl. This domain mediates the association of a heterologous protein with F-actin filaments after microinjection into NIH 3T3 cells, and directly binds to F-actin in a cosedimentation assay. Microinjection and cosedimentation assays localize the actin-binding domain to a 58 amino acid region, including a charged motif at the extreme COOH-terminus that is important for efficient binding. F-actin binding by Abl is calcium independent, and Abl competes with gelsolin for binding to F-actin. In addition to the F-actin binding domain, the COOH-terminus of Abl contains a proline-rich region that mediates binding and sequestration of G-actin, and the Abl F- and G-actin binding domains cooperate to bundle F-actin filaments in vitro. The COOH terminus of Abl thus confers several novel localizing functions upon the protein, including actin binding, nuclear localization, and DNA binding. Abl may modify and receive signals from the F-actin cytoskeleton in vivo, and is an ideal candidate to mediate signal transduction from the cell surface and cytoskeleton to the nucleus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8294516      PMCID: PMC2119935          DOI: 10.1083/jcb.124.3.325

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  70 in total

Review 1.  Integrins: versatility, modulation, and signaling in cell adhesion.

Authors:  R O Hynes
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

2.  Drosophila abl tyrosine kinase in embryonic CNS axons: a role in axonogenesis is revealed through dosage-sensitive interactions with disabled.

Authors:  F B Gertler; R L Bennett; M J Clark; F M Hoffmann
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

3.  The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization.

Authors:  R A Van Etten; P Jackson; D Baltimore
Journal:  Cell       Date:  1989-08-25       Impact factor: 41.582

Review 4.  Pieces in the actin-severing protein puzzle.

Authors:  P Matsudaira; P Janmey
Journal:  Cell       Date:  1988-07-15       Impact factor: 41.582

5.  Homology of a yeast actin-binding protein to signal transduction proteins and myosin-I.

Authors:  D G Drubin; J Mulholland; Z M Zhu; D Botstein
Journal:  Nature       Date:  1990-01-18       Impact factor: 49.962

6.  The src protein contains multiple domains for specific attachment to membranes.

Authors:  J M Kaplan; H E Varmus; J M Bishop
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

7.  Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA.

Authors:  E T Kipreos; J Y Wang
Journal:  Science       Date:  1992-04-17       Impact factor: 47.728

8.  MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium-calmodulin.

Authors:  J H Hartwig; M Thelen; A Rosen; P A Janmey; A C Nairn; A Aderem
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

9.  Primary structure of the brain alpha-spectrin.

Authors:  V M Wasenius; M Saraste; P Salvén; M Erämaa; L Holm; V P Lehto
Journal:  J Cell Biol       Date:  1989-01       Impact factor: 10.539

10.  Gelsolin has three actin-binding sites.

Authors:  J Bryan
Journal:  J Cell Biol       Date:  1988-05       Impact factor: 10.539

View more
  83 in total

1.  Creating a niche in the cytoskeleton: Actin reorganization by a protein kinase.

Authors:  P A Janmey
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  The Abl-related gene (Arg) nonreceptor tyrosine kinase uses two F-actin-binding domains to bundle F-actin.

Authors:  Y Wang; A L Miller; M S Mooseker; A J Koleske
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

3.  Role of c-Abl in L-selectin shedding from the neutrophil surface.

Authors:  Carissa J Ball; Michael R King
Journal:  Blood Cells Mol Dis       Date:  2011-02-01       Impact factor: 3.039

4.  Interaction between UV-damaged DNA binding activity proteins and the c-Abl tyrosine kinase.

Authors:  Feng Cong; Jean Tang; Byung Joon Hwang; Bao Q Vuong; Gilbert Chu; Stephen P Goff
Journal:  J Biol Chem       Date:  2002-07-09       Impact factor: 5.157

5.  A chimeric receptor/oncogene that can be regulated by a ligand in vitro and in vivo.

Authors:  K Okuda; A D'Andrea; R A Etten; J D Griffin
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

6.  BCR/ABL induces multiple abnormalities of cytoskeletal function.

Authors:  R Salgia; J L Li; D S Ewaniuk; W Pear; E Pisick; S A Burky; T Ernst; M Sattler; L B Chen; J D Griffin
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

7.  Quantitative phosphotyrosine proteomics of EphB2 signaling by stable isotope labeling with amino acids in cell culture (SILAC).

Authors:  Guoan Zhang; Daniel S Spellman; Edward Y Skolnik; Thomas A Neubert
Journal:  J Proteome Res       Date:  2006-03       Impact factor: 4.466

8.  Gag influences transformation by Abelson murine leukemia virus and suppresses nuclear localization of the v-Abl protein.

Authors:  Chae-Ryun Yi; Naomi Rosenberg
Journal:  J Virol       Date:  2007-06-27       Impact factor: 5.103

Review 9.  Abl tyrosine kinases in T-cell signaling.

Authors:  Jing Jin Gu; Jae Ryun Ryu; Ann Marie Pendergast
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

10.  SRC points the way to biomarkers and chemotherapeutic targets.

Authors:  Harini Krishnan; W Todd Miller; Gary S Goldberg
Journal:  Genes Cancer       Date:  2012-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.